International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

被引：442
作者：
Kotton, Camille N. [1 ]
Kumar, Deepali
Caliendo, Angela M. [2 ]
Asberg, Anders [3 ]
Chou, Sunwen [4 ]
Snydman, David R. [5 ,6 ]
Allen, Upton [7 ]
Humar, Atul
机构：
[1] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[2] Emory Univ Hosp, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[3] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway
[4] Oregon Hlth & Sci Univ, Div Infect Dis L457, Portland, OR 97201 USA
[5] Tufts Univ, Sch Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA
[6] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA
[7] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada
来源：
TRANSPLANTATION | 2010年 / 89卷 / 07期
关键词：
Cytomegalovirus; Prophylaxis; Resistance; Ganciclovir; Valganciclovir; GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS; T-CELL RESPONSES; BRONCHOALVEOLAR LAVAGE FLUID; GUIDING PREEMPTIVE THERAPY; AMPLICOR CMV MONITOR; LIVER-TRANSPLANT; RENAL-TRANSPLANT; DRUG-RESISTANCE; INTRAVENOUS GANCICLOVIR; VALGANCICLOVIR THERAPY;
D O I：
10.1097/TP.0b013e3181cee42f
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.
引用
收藏
页码：779 / 795
页数：17
相关论文
共 152 条
[1]  
[Anonymous], 1996, Arch Ophthalmol, V114, P23
[2]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[3]   Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation [J].
Arthurs, Supha K. ;
Eid, Albert J. ;
Pedersen, Rachel A. ;
Kremers, Walter K. ;
Cosio, Fernando G. ;
Patel, Robin ;
Razonable, Raymund R. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (06) :840-846
[4]   Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients [J].
Asberg, A. ;
Humar, A. ;
Rollag, H. ;
Jardine, A. G. ;
Mouas, H. ;
Pescovitz, M. D. ;
Sgarabotto, D. ;
Tuncer, M. ;
Noronha, I. L. ;
Hartmann, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (09) :2106-2113
[5]   Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients [J].
Asberg, A. ;
Humar, A. ;
Jardine, A. G. ;
Rollag, H. ;
Pescovitz, M. D. ;
Mouas, H. ;
Bignamini, A. ;
Toez, H. ;
Dittmer, I. ;
Montejo, M. ;
Hartmann, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) :1205-1213
[6]   Update in management of ganciclovir-resistant cytomegalovirus infection [J].
Avery, Robin K. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (04) :433-437
[7]   Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs [J].
Baldanti, F ;
Lurain, N ;
Gerna, G .
HUMAN IMMUNOLOGY, 2004, 65 (05) :403-409
[8]   Monitoring human cytomegalovirus infection in transplant recipients [J].
Baldanti, Fausto ;
Lilleri, Daniele ;
Gerna, Giuseppe .
JOURNAL OF CLINICAL VIROLOGY, 2008, 41 (03) :237-241
[9]   OPTIONS FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE [J].
BALFOUR, HH .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (07) :598-599
[10]   Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation [J].
Battiwalla, M. ;
Paplham, P. ;
Almyroudis, N. G. ;
McCarthy, A. ;
Abdelhalim, A. ;
Elefante, A. ;
Smith, P. ;
Becker, J. ;
McCarthy, P. L. ;
Segal, B. H. .
TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) :28-32
12345678910